These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9743931)

  • 1. [New drugs in glaucoma therapy].
    Gramer E
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):aA10-2. PubMed ID: 9743931
    [No Abstract]   [Full Text] [Related]  

  • 2. New medical therapies for glaucoma.
    Drake MV
    Int Ophthalmol Clin; 1996; 36(2):53-60. PubMed ID: 8950633
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
    Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
    Ophthalmology; 2005 Apr; 112(4):603-8. PubMed ID: 15808251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
    Gebhardt DO
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):275. PubMed ID: 10086159
    [No Abstract]   [Full Text] [Related]  

  • 8. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Cvenkel B; Stewart JA; Nelson LA; Stewart WC
    Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroprotection and vasoprotection in glaucoma].
    Ignat F
    Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Open-angle glaucoma associated with Groenblad-Strandberg syndrome].
    Dumitrica DM; Stefan C
    Oftalmologia; 2008; 52(4):44-52. PubMed ID: 19354162
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modern anti-glaucoma drugs and their secondary effects].
    Mermoud A
    Rev Med Suisse Romande; 1998 Nov; 118(11):937-40. PubMed ID: 9865122
    [No Abstract]   [Full Text] [Related]  

  • 15. [The ocular hypotensive effect of the combination of latanoprost with dorzolamide].
    Chiselita D; Apatachioae I; Poiata I
    Oftalmologia; 1999; 46(1):39-45. PubMed ID: 10641085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual side effect of Dorzolamide.
    Zambarakji HJ; Spencer AF; Vernon SA
    Eye (Lond); 1997; 11 ( Pt 3)():418-9. PubMed ID: 9373489
    [No Abstract]   [Full Text] [Related]  

  • 17. Switching from dorzolamide to brinzolamide: effect on intraocular pressure and patient comfort.
    Inoue K; Wada SA; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2006; 50(1):68-9. PubMed ID: 16453193
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological advances in the treatment of glaucoma.
    Serle JB
    Drugs Aging; 1994 Sep; 5(3):156-70. PubMed ID: 7803944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
    Hoyng PF; Rasker MT
    Ned Tijdschr Geneeskd; 1998 Sep; 142(39):2138-41. PubMed ID: 9856229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
    Konstas AG; Kozobolis VP; Tsironi S; Makridaki I; Efremova R; Stewart WC
    Ophthalmology; 2008 Jan; 115(1):99-103. PubMed ID: 18166407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.